百赛飞完成新一轮融资 金雨茂物领投

Core Insights - The company, Jiangsu Baiseifei Biotechnology Co., Ltd., has completed a new round of financing led by Jinyumaowu, with participation from existing shareholders [1][2] - Baiseifei is recognized as a national "specialized and innovative" small giant in the field of biomaterials surface modification technology, having established a comprehensive technical service platform for functional coatings since its inception in 2017 [1][2] Company Overview - Baiseifei has created a full industrial chain for functional coatings, including self-developed medical coating products, automated coating equipment/production lines, and AI quality inspection and analysis instruments [1] - The company holds the most patents related to medical coatings in China and has established the first industry standards for the adhesion of interventional medical device coatings [1] - Baiseifei has built a large-scale production base that complies with both hazardous chemicals and medical product standards, and its coatings have received NMPA, FDA, or CE medical device registrations [1] Financing Impact - The new financing is expected to accelerate Baiseifei's technological innovation and global market expansion [2] - The company aims to enhance advanced surface modification technology and create an internationally leading high-performance coating platform [2] - Baiseifei plans to leverage its one-stop functional coating solutions to promote the large-scale production and market launch of innovative medical devices with special functional coatings [2] Strategic Vision - The founder, Chen Hong, emphasizes that this financing marks a new starting point for the company, aiming for a "triple leap" in technology, production capacity, and intelligence [2] - The investment leader from Jinyumaowu highlights Baiseifei's unique position as a technology platform with both leading surface modification technology and solid industrialization achievements [2]